HomeALT • NASDAQ
Altimmune Inc
add
$3.87
8.40%
After Hours:(1.55%)+0.060
$3.93
Closed: Sep 18, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 5.00K | 0.00% |
Operating expense | 5.69M | 1.72% |
Net income | -22.15M | 10.12% |
Net profit margin | -442.92K | 10.12% |
Earnings per share | -0.27 | 22.86% |
EBITDA | -22.89M | 14.21% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 183.11M | 11.03% |
Total assets | 190.35M | 9.81% |
Total liabilities | 28.98M | 39.24% |
Total equity | 161.37M | — |
Shares outstanding | 88.26M | — |
Price to book | 1.88 | — |
Return on assets | -32.97% | — |
Return on capital | -35.71% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -22.15M | 10.12% |
Cash from operations | -19.35M | -6.86% |
Cash from investing | 101.11M | 2,835.58% |
Cash from financing | 52.24M | 113,673.91% |
Net change in cash | 134.00M | 713.28% |
Free cash flow | -11.30M | -23.55% |
Previous close
$3.57
Day range
$3.67 - $4.19
Year range
$2.91 - $11.16
Market cap
341.56M USD
Avg Volume
2.64M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1997
Headquarters
Website
Employees
59
